Загрузка...

Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors

Although the clinical development of immune checkpoint inhibitors (ICIs) therapy has ushered in a new era of anti-tumor therapy, with sustained responses and significant survival advantages observed in multiple tumors, most patients do not benefit. Therefore, more and more attention has been paid to...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Biomark Res
Главные авторы: Bai, Rilan, Lv, Zheng, Xu, Dongsheng, Cui, Jiuwei
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2020
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7450548/
https://ncbi.nlm.nih.gov/pubmed/32864131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-020-00209-0
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!